Global Opioids Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at US$ 9975 million in 2024 and is forecast to a readjusted size of USD 8823 million by 2031 with a CAGR of -1.8% during review period.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report is a detailed and comprehensive analysis for global Opioids Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Opioids Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioids Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Opioids Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales quantity, revenue, and global market share of Opioids Drug from 2020 to 2025.
Chapter 3, the Opioids Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Opioids Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids Drug.
Chapter 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report is a detailed and comprehensive analysis for global Opioids Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Opioids Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2020-2031
Global Opioids Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Opioids Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Opioids Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales quantity, revenue, and global market share of Opioids Drug from 2020 to 2025.
Chapter 3, the Opioids Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Opioids Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Opioids Drug.
Chapter 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Oxycodone
1.3.3 Hydromorphone
1.3.4 Codeine
1.3.5 Fentanyl
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pain Relief
1.4.3 Anesthesia
1.4.4 Others
1.5 Global Opioids Drug Market Size & Forecast
1.5.1 Global Opioids Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Opioids Drug Sales Quantity (2020-2031)
1.5.3 Global Opioids Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Drug Product and Services
2.1.4 Teva Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Teva Recent Developments/Updates
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Drug Product and Services
2.2.4 Purdue Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Purdue Pharma Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Drug Product and Services
2.3.4 Mallinckrodt Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Drug Product and Services
2.4.4 Amneal Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Amneal Pharma Recent Developments/Updates
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Drug Product and Services
2.5.4 Collegium Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Collegium Recent Developments/Updates
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Drug Product and Services
2.6.4 J&J Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 J&J Recent Developments/Updates
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Drug Product and Services
2.7.4 Endo Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Endo Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Drug Product and Services
2.8.4 Pfizer Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Pfizer Recent Developments/Updates
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Drug Product and Services
2.9.4 INSYS Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 INSYS Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Drug Product and Services
2.10.4 Mylan Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Mylan Recent Developments/Updates
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Drug Product and Services
2.11.4 Hikma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hikma Recent Developments/Updates
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Drug Product and Services
2.12.4 Egalet Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Egalet Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS DRUG BY MANUFACTURER
3.1 Global Opioids Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global Opioids Drug Revenue by Manufacturer (2020-2025)
3.3 Global Opioids Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Opioids Drug Manufacturer Market Share in 2024
3.4.3 Top 6 Opioids Drug Manufacturer Market Share in 2024
3.5 Opioids Drug Market: Overall Company Footprint Analysis
3.5.1 Opioids Drug Market: Region Footprint
3.5.2 Opioids Drug Market: Company Product Type Footprint
3.5.3 Opioids Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Drug Market Size by Region
4.1.1 Global Opioids Drug Sales Quantity by Region (2020-2031)
4.1.2 Global Opioids Drug Consumption Value by Region (2020-2031)
4.1.3 Global Opioids Drug Average Price by Region (2020-2031)
4.2 North America Opioids Drug Consumption Value (2020-2031)
4.3 Europe Opioids Drug Consumption Value (2020-2031)
4.4 Asia-Pacific Opioids Drug Consumption Value (2020-2031)
4.5 South America Opioids Drug Consumption Value (2020-2031)
4.6 Middle East & Africa Opioids Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Drug Sales Quantity by Type (2020-2031)
5.2 Global Opioids Drug Consumption Value by Type (2020-2031)
5.3 Global Opioids Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Drug Sales Quantity by Application (2020-2031)
6.2 Global Opioids Drug Consumption Value by Application (2020-2031)
6.3 Global Opioids Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Opioids Drug Sales Quantity by Type (2020-2031)
7.2 North America Opioids Drug Sales Quantity by Application (2020-2031)
7.3 North America Opioids Drug Market Size by Country
7.3.1 North America Opioids Drug Sales Quantity by Country (2020-2031)
7.3.2 North America Opioids Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Opioids Drug Sales Quantity by Type (2020-2031)
8.2 Europe Opioids Drug Sales Quantity by Application (2020-2031)
8.3 Europe Opioids Drug Market Size by Country
8.3.1 Europe Opioids Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe Opioids Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Opioids Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Opioids Drug Market Size by Region
9.3.1 Asia-Pacific Opioids Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Opioids Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Opioids Drug Sales Quantity by Type (2020-2031)
10.2 South America Opioids Drug Sales Quantity by Application (2020-2031)
10.3 South America Opioids Drug Market Size by Country
10.3.1 South America Opioids Drug Sales Quantity by Country (2020-2031)
10.3.2 South America Opioids Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Opioids Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Opioids Drug Market Size by Country
11.3.1 Middle East & Africa Opioids Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Opioids Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Opioids Drug Market Drivers
12.2 Opioids Drug Market Restraints
12.3 Opioids Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids Drug
13.3 Opioids Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Drug Typical Distributors
14.3 Opioids Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Opioids Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Oxycodone
1.3.3 Hydromorphone
1.3.4 Codeine
1.3.5 Fentanyl
1.4 Market Analysis by Application
1.4.1 Overview: Global Opioids Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pain Relief
1.4.3 Anesthesia
1.4.4 Others
1.5 Global Opioids Drug Market Size & Forecast
1.5.1 Global Opioids Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Opioids Drug Sales Quantity (2020-2031)
1.5.3 Global Opioids Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Drug Product and Services
2.1.4 Teva Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Teva Recent Developments/Updates
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Drug Product and Services
2.2.4 Purdue Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Purdue Pharma Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Drug Product and Services
2.3.4 Mallinckrodt Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Drug Product and Services
2.4.4 Amneal Pharma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Amneal Pharma Recent Developments/Updates
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Drug Product and Services
2.5.4 Collegium Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Collegium Recent Developments/Updates
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Drug Product and Services
2.6.4 J&J Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 J&J Recent Developments/Updates
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Drug Product and Services
2.7.4 Endo Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Endo Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Drug Product and Services
2.8.4 Pfizer Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Pfizer Recent Developments/Updates
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Drug Product and Services
2.9.4 INSYS Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 INSYS Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Drug Product and Services
2.10.4 Mylan Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Mylan Recent Developments/Updates
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Drug Product and Services
2.11.4 Hikma Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hikma Recent Developments/Updates
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Drug Product and Services
2.12.4 Egalet Opioids Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Egalet Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OPIOIDS DRUG BY MANUFACTURER
3.1 Global Opioids Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global Opioids Drug Revenue by Manufacturer (2020-2025)
3.3 Global Opioids Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Opioids Drug Manufacturer Market Share in 2024
3.4.3 Top 6 Opioids Drug Manufacturer Market Share in 2024
3.5 Opioids Drug Market: Overall Company Footprint Analysis
3.5.1 Opioids Drug Market: Region Footprint
3.5.2 Opioids Drug Market: Company Product Type Footprint
3.5.3 Opioids Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Opioids Drug Market Size by Region
4.1.1 Global Opioids Drug Sales Quantity by Region (2020-2031)
4.1.2 Global Opioids Drug Consumption Value by Region (2020-2031)
4.1.3 Global Opioids Drug Average Price by Region (2020-2031)
4.2 North America Opioids Drug Consumption Value (2020-2031)
4.3 Europe Opioids Drug Consumption Value (2020-2031)
4.4 Asia-Pacific Opioids Drug Consumption Value (2020-2031)
4.5 South America Opioids Drug Consumption Value (2020-2031)
4.6 Middle East & Africa Opioids Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Opioids Drug Sales Quantity by Type (2020-2031)
5.2 Global Opioids Drug Consumption Value by Type (2020-2031)
5.3 Global Opioids Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Opioids Drug Sales Quantity by Application (2020-2031)
6.2 Global Opioids Drug Consumption Value by Application (2020-2031)
6.3 Global Opioids Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Opioids Drug Sales Quantity by Type (2020-2031)
7.2 North America Opioids Drug Sales Quantity by Application (2020-2031)
7.3 North America Opioids Drug Market Size by Country
7.3.1 North America Opioids Drug Sales Quantity by Country (2020-2031)
7.3.2 North America Opioids Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Opioids Drug Sales Quantity by Type (2020-2031)
8.2 Europe Opioids Drug Sales Quantity by Application (2020-2031)
8.3 Europe Opioids Drug Market Size by Country
8.3.1 Europe Opioids Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe Opioids Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Opioids Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Opioids Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Opioids Drug Market Size by Region
9.3.1 Asia-Pacific Opioids Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Opioids Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Opioids Drug Sales Quantity by Type (2020-2031)
10.2 South America Opioids Drug Sales Quantity by Application (2020-2031)
10.3 South America Opioids Drug Market Size by Country
10.3.1 South America Opioids Drug Sales Quantity by Country (2020-2031)
10.3.2 South America Opioids Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Opioids Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Opioids Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Opioids Drug Market Size by Country
11.3.1 Middle East & Africa Opioids Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Opioids Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Opioids Drug Market Drivers
12.2 Opioids Drug Market Restraints
12.3 Opioids Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Opioids Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Opioids Drug
13.3 Opioids Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Opioids Drug Typical Distributors
14.3 Opioids Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Opioids Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Opioids Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Drug Product and Services
Table 6. Teva Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Teva Recent Developments/Updates
Table 8. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Purdue Pharma Major Business
Table 10. Purdue Pharma Opioids Drug Product and Services
Table 11. Purdue Pharma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Purdue Pharma Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Opioids Drug Product and Services
Table 16. Mallinckrodt Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharma Major Business
Table 20. Amneal Pharma Opioids Drug Product and Services
Table 21. Amneal Pharma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Amneal Pharma Recent Developments/Updates
Table 23. Collegium Basic Information, Manufacturing Base and Competitors
Table 24. Collegium Major Business
Table 25. Collegium Opioids Drug Product and Services
Table 26. Collegium Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Collegium Recent Developments/Updates
Table 28. J&J Basic Information, Manufacturing Base and Competitors
Table 29. J&J Major Business
Table 30. J&J Opioids Drug Product and Services
Table 31. J&J Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. J&J Recent Developments/Updates
Table 33. Endo Basic Information, Manufacturing Base and Competitors
Table 34. Endo Major Business
Table 35. Endo Opioids Drug Product and Services
Table 36. Endo Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Endo Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Opioids Drug Product and Services
Table 41. Pfizer Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Pfizer Recent Developments/Updates
Table 43. INSYS Basic Information, Manufacturing Base and Competitors
Table 44. INSYS Major Business
Table 45. INSYS Opioids Drug Product and Services
Table 46. INSYS Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. INSYS Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Opioids Drug Product and Services
Table 51. Mylan Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Mylan Recent Developments/Updates
Table 53. Hikma Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Major Business
Table 55. Hikma Opioids Drug Product and Services
Table 56. Hikma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hikma Recent Developments/Updates
Table 58. Egalet Basic Information, Manufacturing Base and Competitors
Table 59. Egalet Major Business
Table 60. Egalet Opioids Drug Product and Services
Table 61. Egalet Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Egalet Recent Developments/Updates
Table 63. Global Opioids Drug Sales Quantity by Manufacturer (2020-2025) & (M Units)
Table 64. Global Opioids Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Opioids Drug Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 66. Market Position of Manufacturers in Opioids Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 68. Opioids Drug Market: Company Product Type Footprint
Table 69. Opioids Drug Market: Company Product Application Footprint
Table 70. Opioids Drug New Market Entrants and Barriers to Market Entry
Table 71. Opioids Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Opioids Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Opioids Drug Sales Quantity by Region (2020-2025) & (M Units)
Table 74. Global Opioids Drug Sales Quantity by Region (2026-2031) & (M Units)
Table 75. Global Opioids Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Opioids Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Opioids Drug Average Price by Region (2020-2025) & (USD/Unit)
Table 78. Global Opioids Drug Average Price by Region (2026-2031) & (USD/Unit)
Table 79. Global Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 80. Global Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 81. Global Opioids Drug Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Opioids Drug Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Opioids Drug Average Price by Type (2020-2025) & (USD/Unit)
Table 84. Global Opioids Drug Average Price by Type (2026-2031) & (USD/Unit)
Table 85. Global Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 86. Global Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 87. Global Opioids Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Opioids Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Opioids Drug Average Price by Application (2020-2025) & (USD/Unit)
Table 90. Global Opioids Drug Average Price by Application (2026-2031) & (USD/Unit)
Table 91. North America Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 92. North America Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 93. North America Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 94. North America Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 95. North America Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 96. North America Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 97. North America Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 100. Europe Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 101. Europe Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 102. Europe Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 103. Europe Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 104. Europe Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 105. Europe Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 108. Asia-Pacific Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 109. Asia-Pacific Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 110. Asia-Pacific Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 111. Asia-Pacific Opioids Drug Sales Quantity by Region (2020-2025) & (M Units)
Table 112. Asia-Pacific Opioids Drug Sales Quantity by Region (2026-2031) & (M Units)
Table 113. Asia-Pacific Opioids Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Opioids Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 116. South America Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 117. South America Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 118. South America Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 119. South America Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 120. South America Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 121. South America Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 124. Middle East & Africa Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 125. Middle East & Africa Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 126. Middle East & Africa Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 127. Middle East & Africa Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 128. Middle East & Africa Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 129. Middle East & Africa Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Opioids Drug Raw Material
Table 132. Key Manufacturers of Opioids Drug Raw Materials
Table 133. Opioids Drug Typical Distributors
Table 134. Opioids Drug Typical Customers
Table 1. Global Opioids Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Opioids Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Drug Product and Services
Table 6. Teva Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Teva Recent Developments/Updates
Table 8. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Purdue Pharma Major Business
Table 10. Purdue Pharma Opioids Drug Product and Services
Table 11. Purdue Pharma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Purdue Pharma Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Opioids Drug Product and Services
Table 16. Mallinckrodt Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Amneal Pharma Major Business
Table 20. Amneal Pharma Opioids Drug Product and Services
Table 21. Amneal Pharma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Amneal Pharma Recent Developments/Updates
Table 23. Collegium Basic Information, Manufacturing Base and Competitors
Table 24. Collegium Major Business
Table 25. Collegium Opioids Drug Product and Services
Table 26. Collegium Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Collegium Recent Developments/Updates
Table 28. J&J Basic Information, Manufacturing Base and Competitors
Table 29. J&J Major Business
Table 30. J&J Opioids Drug Product and Services
Table 31. J&J Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. J&J Recent Developments/Updates
Table 33. Endo Basic Information, Manufacturing Base and Competitors
Table 34. Endo Major Business
Table 35. Endo Opioids Drug Product and Services
Table 36. Endo Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Endo Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Opioids Drug Product and Services
Table 41. Pfizer Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Pfizer Recent Developments/Updates
Table 43. INSYS Basic Information, Manufacturing Base and Competitors
Table 44. INSYS Major Business
Table 45. INSYS Opioids Drug Product and Services
Table 46. INSYS Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. INSYS Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Opioids Drug Product and Services
Table 51. Mylan Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Mylan Recent Developments/Updates
Table 53. Hikma Basic Information, Manufacturing Base and Competitors
Table 54. Hikma Major Business
Table 55. Hikma Opioids Drug Product and Services
Table 56. Hikma Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hikma Recent Developments/Updates
Table 58. Egalet Basic Information, Manufacturing Base and Competitors
Table 59. Egalet Major Business
Table 60. Egalet Opioids Drug Product and Services
Table 61. Egalet Opioids Drug Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Egalet Recent Developments/Updates
Table 63. Global Opioids Drug Sales Quantity by Manufacturer (2020-2025) & (M Units)
Table 64. Global Opioids Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Opioids Drug Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 66. Market Position of Manufacturers in Opioids Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 68. Opioids Drug Market: Company Product Type Footprint
Table 69. Opioids Drug Market: Company Product Application Footprint
Table 70. Opioids Drug New Market Entrants and Barriers to Market Entry
Table 71. Opioids Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Opioids Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Opioids Drug Sales Quantity by Region (2020-2025) & (M Units)
Table 74. Global Opioids Drug Sales Quantity by Region (2026-2031) & (M Units)
Table 75. Global Opioids Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Opioids Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Opioids Drug Average Price by Region (2020-2025) & (USD/Unit)
Table 78. Global Opioids Drug Average Price by Region (2026-2031) & (USD/Unit)
Table 79. Global Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 80. Global Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 81. Global Opioids Drug Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Opioids Drug Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Opioids Drug Average Price by Type (2020-2025) & (USD/Unit)
Table 84. Global Opioids Drug Average Price by Type (2026-2031) & (USD/Unit)
Table 85. Global Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 86. Global Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 87. Global Opioids Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Opioids Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Opioids Drug Average Price by Application (2020-2025) & (USD/Unit)
Table 90. Global Opioids Drug Average Price by Application (2026-2031) & (USD/Unit)
Table 91. North America Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 92. North America Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 93. North America Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 94. North America Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 95. North America Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 96. North America Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 97. North America Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 100. Europe Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 101. Europe Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 102. Europe Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 103. Europe Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 104. Europe Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 105. Europe Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 108. Asia-Pacific Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 109. Asia-Pacific Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 110. Asia-Pacific Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 111. Asia-Pacific Opioids Drug Sales Quantity by Region (2020-2025) & (M Units)
Table 112. Asia-Pacific Opioids Drug Sales Quantity by Region (2026-2031) & (M Units)
Table 113. Asia-Pacific Opioids Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Opioids Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 116. South America Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 117. South America Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 118. South America Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 119. South America Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 120. South America Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 121. South America Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Opioids Drug Sales Quantity by Type (2020-2025) & (M Units)
Table 124. Middle East & Africa Opioids Drug Sales Quantity by Type (2026-2031) & (M Units)
Table 125. Middle East & Africa Opioids Drug Sales Quantity by Application (2020-2025) & (M Units)
Table 126. Middle East & Africa Opioids Drug Sales Quantity by Application (2026-2031) & (M Units)
Table 127. Middle East & Africa Opioids Drug Sales Quantity by Country (2020-2025) & (M Units)
Table 128. Middle East & Africa Opioids Drug Sales Quantity by Country (2026-2031) & (M Units)
Table 129. Middle East & Africa Opioids Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Opioids Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Opioids Drug Raw Material
Table 132. Key Manufacturers of Opioids Drug Raw Materials
Table 133. Opioids Drug Typical Distributors
Table 134. Opioids Drug Typical Customers
LIST OF FIGURES
Figure 1. Opioids Drug Picture
Figure 2. Global Opioids Drug Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Opioids Drug Revenue Market Share by Type in 2024
Figure 4. Oxycodone Examples
Figure 5. Hydromorphone Examples
Figure 6. Codeine Examples
Figure 7. Fentanyl Examples
Figure 8. Global Opioids Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Opioids Drug Revenue Market Share by Application in 2024
Figure 10. Pain Relief Examples
Figure 11. Anesthesia Examples
Figure 12. Others Examples
Figure 13. Global Opioids Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Opioids Drug Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Opioids Drug Sales Quantity (2020-2031) & (M Units)
Figure 16. Global Opioids Drug Price (2020-2031) & (USD/Unit)
Figure 17. Global Opioids Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Opioids Drug Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Opioids Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Opioids Drug Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Opioids Drug Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Opioids Drug Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Opioids Drug Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Opioids Drug Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Opioids Drug Average Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Opioids Drug Revenue Market Share by Application (2020-2031)
Figure 34. Global Opioids Drug Average Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 47. France Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Opioids Drug Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Opioids Drug Consumption Value Market Share by Region (2020-2031)
Figure 55. China Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. India Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. Opioids Drug Market Drivers
Figure 76. Opioids Drug Market Restraints
Figure 77. Opioids Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Opioids Drug in 2024
Figure 80. Manufacturing Process Analysis of Opioids Drug
Figure 81. Opioids Drug Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Opioids Drug Picture
Figure 2. Global Opioids Drug Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Opioids Drug Revenue Market Share by Type in 2024
Figure 4. Oxycodone Examples
Figure 5. Hydromorphone Examples
Figure 6. Codeine Examples
Figure 7. Fentanyl Examples
Figure 8. Global Opioids Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Opioids Drug Revenue Market Share by Application in 2024
Figure 10. Pain Relief Examples
Figure 11. Anesthesia Examples
Figure 12. Others Examples
Figure 13. Global Opioids Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Opioids Drug Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Opioids Drug Sales Quantity (2020-2031) & (M Units)
Figure 16. Global Opioids Drug Price (2020-2031) & (USD/Unit)
Figure 17. Global Opioids Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Opioids Drug Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Opioids Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Opioids Drug Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Opioids Drug Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Opioids Drug Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Opioids Drug Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Opioids Drug Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Opioids Drug Average Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Opioids Drug Revenue Market Share by Application (2020-2031)
Figure 34. Global Opioids Drug Average Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 47. France Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Opioids Drug Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Opioids Drug Consumption Value Market Share by Region (2020-2031)
Figure 55. China Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. India Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Opioids Drug Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Opioids Drug Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Opioids Drug Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Opioids Drug Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Opioids Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. Opioids Drug Market Drivers
Figure 76. Opioids Drug Market Restraints
Figure 77. Opioids Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Opioids Drug in 2024
Figure 80. Manufacturing Process Analysis of Opioids Drug
Figure 81. Opioids Drug Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
